Axovant Sciences Ltd. (AXON) Institutional Holdings Reach $12 million

Axovant Sciences Ltd. (NASDAQ:AXON) is at least 39.78% than its current record low price of $0.93. There was a 4% gain on 02/11/2019 that led the price to move at $1.3. At recent session, the prices were hovering between $1.21 and $1.34. This company shares are 238.46% off its target price of $4.4 and the current market capitalization stands at $197.08M. The recent change has given its price a 9.1% lead over SMA 50 and -80.27% deficit over its 52-week high. The stock witnessed 13.04% gains, -36.59% declines and -36.27% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found AXON’s volatility during a week at 11.69% and during a month it has been found around 7.8%.

Axovant Sciences Ltd. (AXON) Top Holders

Institutional investors currently hold around $12 million or 18.7% in AXON stock. Look at its top three institutional owners. Renaissance Technologies Llc owns $2.62 million in Axovant Sciences Ltd., which represents roughly 1.33% of the company’s market cap and approximately 21.79% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 1,374,670 shares of the stock are valued at $1.72 million. The third largest holder is Primecap Management Co/Ca/, which currently holds $1.35 million worth of this stock and that ownership represents nearly 0.69% of its market capitalization.

Axovant Sciences Ltd. 13F Filings

At the end of September reporting period, 15 institutional holders increased their position in Axovant Sciences Ltd. (NASDAQ:AXON) by some 1,168,417 shares, 40 decreased positions by 3,136,425 and 20 held positions by 4,900,963. That puts total institutional holdings at 9,205,805 shares, according to SEC filings. The stock grabbed 5 new institutional investments totaling 60,842 shares while 18 institutional investors sold out their entire positions totaling 812,493 shares.

Axovant Sciences Ltd. (NASDAQ:AXON) Insider Trades

Multiple company employees have indulged in significant insider trading. Axovant Sciences Ltd. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that 10% Owner Viking Global Investors Lp has acquired 10,000,000 shares of Axovant Sciences Ltd. (AXON) in trading session dated Dec. 18, 2018. These shares are worth $10,000,000 and were traded at $1 each. The SEC filing shows that Viking Global Performance Llc performed a purchase of 10,000,000 shares. The 10% Owner added these shares by way of transaction on Dec. 18, 2018. The company’s shares were assimilated at $1 per share worth to an investment of some $10,000,000 on account of Viking Global Performance Llc.

10% Owner, Lo Andrew, purchased 10,000,000 common shares of Axovant Sciences Ltd. (AXON) in the open market. In a transaction dated Dec. 18, 2018, the shares were bought at an average price of $1, giving away a sum of $10,000,000. After this purchase, 99,285,714 common shares of AXON are directly owned by the insider, with total stake valued at $129,071,428.

In the transaction dated Dec. 18, 2018, the great number of shares acquired came courtesy the 10% Owner; Svf Investments (Uk) Ltd added a total of 10,000,000 shares at an average price of $1, amounting to approximately $10,000,000. The insider now directly owns 99,285,714 shares worth $129,071,428.

Axovant Sciences Ltd. (AXON) Analyst Guide

Several analysts have released their opinion on Axovant Sciences Ltd. (NASDAQ:AXON), with 1 analysts believing it is a strong buy. Whereas 3 of them predict the stock is a hold. Also, there are 2 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.33 average brokerage recommendation.